Results 231 to 240 of about 185,022 (244)

3D Bioprinted Blood–Brain–Tumor Barrier Spheroid‐Based In Situ Evaluation of Anticancer Compounds Against Glioblastoma: ROS‐Producing Ruthenium as a Potential Therapeutic Candidate

open access: yesAdvanced Science, EarlyView.
The blood–brain–tumor barrier (BBTB) penetration by anticancer drugs and their effects on glioblastoma (GBM) is assessed using 3D bioprinted‐spheroids. Anticancer drug‐induced U‐87 MG cell death is quantified through in situ imaging of spheroids using a cancer cell death probe. The Ru compound, a partial P‐gp substrate, induces greater tumor‐cell death
Hyunjung Lee   +5 more
wiley   +1 more source

Unlocking the brain: Biodistribution insights into tween 80 nanoliposomes in healthy brains. [PDF]

open access: yesInt J Pharm X
Khatibi M   +8 more
europepmc   +1 more source

Galectin-3 restrains T cell-driven inflammation in the testis and epididymis. [PDF]

open access: yesCell Death Dis
Hasan H   +18 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy